Michael P Hughes Selected Research

Michael P Hughes Research Topics

2	Disease Progression 01/2018 - 01/2014
2	Neoplasms (Cancer) 03/2008 - 09/2003
1	Amyloidosis 01/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2022
1	Osteoarthritis 11/2021
1	Atrophy 01/2020
1	Parkinsonian Disorders (Parkinsonism) 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Lewy Body Disease (Lewy Body Dementia) 01/2020
1	Dementia (Dementias) 01/2020
1	Gaucher Disease (Gaucher's Disease) 01/2020
1	Epilepsy (Aura) 01/2019
1	Neuromuscular Diseases (Neuromuscular Disease) 11/2018
1	Muscular Diseases (Myopathy) 11/2018
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2018
1	Argininosuccinic Aciduria 01/2018
1	Asphyxia (Suffocation) 01/2016
1	Hypoxia (Hypoxemia) 01/2016
1	Ischemia 01/2016
1	Metabolic Diseases (Metabolic Disease) 07/2013
1	Alzheimer Disease (Alzheimer's Disease) 07/2013
1	Type 2 Diabetes Mellitus (MODY) 07/2013
1	Infections 10/2007
1	Breast Neoplasms (Breast Cancer) 04/2007
1	Squamous Cell Carcinoma of Head and Neck 02/2007
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2006

2	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2013
2	Amyloidogenic ProteinsIBA 01/2022 - 07/2013
2	Amyloid (Amyloid Fibrils)IBA 11/2018 - 07/2013
2	Pharmaceutical PreparationsIBA 01/2018 - 04/2007
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2008 - 10/2007
1	SynucleinsIBA 01/2020
1	Synapsins (Synapsin I)IBA 01/2020
1	EnzymesIBA 01/2020
1	Glucosylceramidase (Glucocerebrosidase)IBA 01/2020
1	Potassium Channels (Potassium Channel)IBA 01/2019
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 11/2018
1	Urea (Carbamide)FDA LinkGeneric 01/2018
1	miglustat (Zavesca)FDA Link 01/2018
1	AmmoniaIBA 01/2018
1	Argininosuccinate LyaseIBA 01/2018
1	CitrullineIBA 01/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018
1	3-nitrotyrosineIBA 01/2016
1	Amyloid beta-PeptidesIBA 07/2013
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 03/2008
1	Ion Channels (Ion Channel)IBA 03/2008
1	Ciprofloxacin (Cipro)FDA LinkGeneric 10/2007
1	StaurosporineIBA 01/2006
1	Biological ProductsIBA 09/2003

5	Therapeutics 11/2021 - 02/2007
1	Ischemic Postconditioning 01/2016